The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample (Q40599163)
Jump to navigation
Jump to search
scientific article published on May 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample |
scientific article published on May 2003 |
Statements
1 reference
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample (English)
1 reference
T H McGlashan
1 reference
T J Miller
1 reference
R B Zipursky
1 reference
D Perkins
1 reference
J Addington
1 reference
S W Woods
1 reference
K A Hawkins
1 reference
R Hoffman
1 reference
A Preda
1 reference
I Epstein
1 reference
D Addington
1 reference
S Lindborg
1 reference
E Marquez
1 reference
M Tohen
1 reference
A Breier
1 reference
1 May 2003
1 reference
1 reference
61
1 reference
1
1 reference
19-30
1 reference
Identifiers
1 reference
1 reference